Two icodextrin exchanges per day in peritoneal dialysis patients with ultrafiltration failure: One center's experience and review of the literature

International Urology and Nephrology

Volumn 43, Issue 1, 2011, Pages 203-209

  Dousdampanis, Periklis ^a   Trigka, Konstantza ^a   Chu, Maggie ^a   Khan, Saimah ^a   Venturoli, Daniele ^b   Oreopoulos, Dimitrios G ^a   Bargman, Joanne M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Computer simulations; Dextrose solutions; Icodextrin; Peritoneal dialysis; Ultrafiltration failure

Indexed keywords

CREATININE; EXTRANEAL; HEMOGLOBIN A1C; ICODEXTRIN; INSULIN; SODIUM;

ADULT; BODY WEIGHT; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; HUMAN; LONG TERM CARE; MALE; MEAN ARTERIAL PRESSURE; PATIENT SAFETY; PERITONEAL DIALYSIS; REVIEW; SODIUM BLOOD LEVEL; ULTRAFILTRATION; WEIGHT REDUCTION;

CREATININE; DIALYSIS SOLUTIONS; FEMALE; GLUCANS; GLUCOSE; HEMODIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEUM; ULTRAFILTRATION;

EID: 79953818842     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-010-9716-9     Document Type: Review

References (32)

1. Li PK, Chow KM (2007) Maximizing the success of peritoneal dialysis in high transporters. Perit Dial Int 27(Suppl 2):S148-S152 (Pubitemid 350047692)
2. De Vriese AS, Mortier S, Lameire NH (2001) Glucotoxicity of the peritoneal membrane: the case for VEGF. Nephrol Dial Transplant 16:2299-2302 (Pubitemid 33133841)
3. Davies SJ, Phillips L, Naish PF, Russell GI (2001) Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12:1046-1051 (Pubitemid 32378346)
4. Burkart J (2004) Metabolic consequences of peritoneal dialysis. Semin Dial 17:498-504
5. Jolly S, Chatatalsingh C, Bargman J, Vas S, Chu M, Oreopoulos DG (2001) Excessive weight gain during peritoneal dialysis. Int J Artif Organs 24:197-202 (Pubitemid 32479376)
6. Rippe B, Levin L (2000) Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD. Kidney Int 57:2546-2556 (Pubitemid 30340753)
7. Finkelstein F, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, Nash K, Sorkin M, Mujais S, The Icodextrin High Transport Trial Group (2005) Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 16:546-554
8. Davies DS (1994) Kinetics of icodextrin. Perit Dial Int 14(Suppl 2):S45-S50
9. Posthuma N, ter Wee PM et al (2000) Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The dextrin in APD in Amsterdam(DIANA) group. PeritDial Int 20(S2):S106-S113
10. Liakopoulos V, Zarogiannis S, Eleftheriadis T, Dovas S, Stefanidis I (2007) Significant intra- and interpatient variation in ultrafiltration achieved by icodextrin in APD patients. Perit Dial Int 27(1):97-98 (Pubitemid 46403293)
11. Ahmad M, Jeloka T, Pliakogiannis T, Tapiawala S, Zhong H, Bargman JM, Oreopoulos D (2008) Icodextrin produces higher ultrafiltration in diabetics that in non-diabetic patients on continous cyclic peritoneal dialysis. Int Urol Nephrol 40(1):219-223
12. Jeloka TK, Ersoy FF, Yavuz M, Sahu KM, Camsari T, Utah C et al (2006) What is the optimal dwell time for maximizing ultrafiltration with icodextrin exchange in automated peritoneal dialysis patients? Perit Dial Int 26(3):336-340
13. ISPD ed hoc committee on ultrafiltration management in peritoneal dialysis (2000) Perit Dial Int 20 (Suppl 4): S3-S4
14. Wolfson M, Ogrinc F, Mujais S (2002) Review of clinical trial experience with icodextrin. Kidney Int Suppl( 81):S46-S52
15. Wilkie ME, Plant MJ, Edwards L, Brown CB (1997) Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technical survival. Perit Dial Int 17:84-87 (Pubitemid 27475054)
16. Gokal R, Moberly J, Lindholm B, Mujais S (2002) Metabolic and laboratory effects of icodextrin. Kidney Int Suppl (81):S62-S71
17. Babazono T, Nakamoto H, Kasai K, Kuriyama S, Sugimoto T, Nakayama M, Hamada C, Furuya R, Hasegawa H, Kasahara M, Moriishi M, Tomo T, Miyazaki M, Sato M, Yorioka N, Kawaguchi Y, Japanese Extraneal Collaborated Study Group (2007) Effects of icodextrin on glycemic and lipid profiles in diabetic patients undergoing peritoneal dialysis. Am J Nephrol 27(4):409-415
18. Paniagua R, Ventura MD, Avila-Diaz M, Cisneros A, Vicente-Martinez M et al (2009) Icodextrin improves metabolic and fluid management in high and high average transport diabetic patients. Perit Dial Int 29(4):422-432
19. Hithaisi C, Lobbedez T, Padmanabhan S, Pineda ME, Oreopoulos DG (2004) No beneficial effect of icodextrin on blood glucose control. Perit Dial Int 24(2):199-200 (Pubitemid 38515090)
20. Gokal R, Mistry CD, Peers EM (1995) Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS study group. Multicenter investigation of icodextrin in ambulatory dialysis. Perit Dial Int 15:226-230
21. Posthuma N, ter Weel PM, Donker AJ et al (1998) Icodextrin use in CCPD patients during peritonitis: ultrafiltration and serum disaccharide concentrations. Nephrol Dial Transplant 13(9):2341-2344
22. Ahmad M, Shah H, Pliakogiannis T, Oreopoulos DG (2007) Prevention of membrane damage in patient on peritoneal dialysis with new peritoneal dialysis solutions. Int Urol Nephrol 39(1):299-312 (Pubitemid 46722980)
23. Oreopoulos D, Thodis E, Paraskevas KI (2008) The promising future of long-term peritoneal dialysis. Int Urol Nephrol 40(2):405-410
24. Kössi J, Grönlund S et al (2009) The effect of 4% icodextrin solution on adhesiolysis surgery time at the Hartmann's reversal: a pilot, multicentre, randomized control trial vs lactated Ringer's solution. Colorectal Dis 11(2):168-172
25. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, Divino Filho JC, Vonesh E, Van Bree M, EAPOS Group (2003) Survival of functionally anuric patients on automated peritoneal dialysis: the European APD outcome study. J Am Soc Nephrol 14(11):2948-2957 (Pubitemid 37305658)
26. Gobin J, Fernando S, Santacroce S, Finkelstein FO (2008) The utility of two daytime icodextrin exchanges to reduce dextrose exposure in automated peritoneal dialysis patients: a pilot study of nine patients. Blood Purif 26(3):279-283 (Pubitemid 351748062)
27. Sav T, Oymak O, Inanc MT, Dogan A, Tokgoz B, Utas C (2009) Effects of twice-daily icodextrin administration on blood pressure and left ventricular mass in patients on continous ambulatory peritoneal dialysis. Perit Dial Int 29(4):443-449
28. Mistry CD, Gokal R, Peers E, the MIDAS Study Group (1994) A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solution in CAPD. Kidney Int 46:496-503 (Pubitemid 24253059)
29. Plum J, Gentile S, Verger C, Brunkhorst R, Bahner U, Faller B et al (2002) Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 39: 862-871 (Pubitemid 34263363)
30. Chan TM, Yung S (2007) Studying the effects of new peritoneal dialysis solutions on the peritoneum. Perit Dial Int 27(S2):S87-S93
31. Martikainen TA, Teppo AM, Gronhagen-Riska C, Ekstrand AV (2005) Glucose-free dialysis solutions:inductors of inflammation or preservers of peritoneal membrane? Perit Dial Int 25:453-460
32. Moriishi M, Kawanishi H (2008) Icodextrin and intraperitoneal inflammation. Perit Dial Int 28(S3):S96-S100